Edition:
United States

Conmed Corp (CNMD.OQ)

CNMD.OQ on NASDAQ Stock Exchange Global Select Market

48.75USD
1:14pm EDT
Change (% chg)

$-0.22 (-0.45%)
Prev Close
$48.97
Open
$48.59
Day's High
$48.83
Day's Low
$48.49
Volume
23,512
Avg. Vol
52,649
52-wk High
$52.79
52-wk Low
$37.66

Latest Key Developments (Source: Significant Developments)

MedShape sells ExoShape ACL product line to CONMED Corp
Wednesday, 5 Jul 2017 07:50am EDT 

July 5 (Reuters) - Conmed Corp :Medshape sells exoshape® acl product line to conmed corporation.Medshape inc says ‍conmed to acquire exoshape® acl fixation system​.  Full Article

Conmed Corp reports Q1 adjusted earnings per share $0.38
Wednesday, 26 Apr 2017 04:01pm EDT 

April 26 (Reuters) - Conmed Corp :Conmed Corporation announces first quarter 2017 financial results.Q1 adjusted earnings per share $0.38.Q1 GAAP loss per share $0.16.Q1 sales $186.6 million.Says continues to expect 2017 constant currency sales growth in range of 1% to 3%.Conmed Corp - continues to expect 2017 constant currency sales growth in range of 1% to 3.Conmed Corp - continues to expect 2017 adjusted diluted net earnings per share in range of $1.85 to $1.95.FY2017 earnings per share view $1.89, revenue view $774.6 million -- Thomson Reuters I/B/E/S.  Full Article

Conmed corporation says jury found Surgiquest liable for $2.2 mln in compensatory damages
Tuesday, 11 Apr 2017 09:24pm EDT 

Conmed Corp : Conmed corporation announces jury verdict in delaware litigation against surgiquest . Jury in United States court for district of Delaware returned verdict finding conmed's subsidiary, surgiquest, liable for $2.2 million in compensatory damages . "this litigation will have no impact on availability of, or conmed's ability to distribute" .Conmed corp - surgiquest, is also liable for an additional $10.0 million in punitive damages.  Full Article

Conmed corporation says jury found Surgiquest liable for $2.2 mln in compensatory damages
Tuesday, 11 Apr 2017 06:40pm EDT 

Conmed Corp : Conmed corporation announces jury verdict in delaware litigation against surgiquest . Jury in United States court for district of Delaware returned verdict finding conmed's subsidiary, surgiquest, liable for $2.2 million in compensatory damages . "this litigation will have no impact on availability of, or conmed's ability to distribute" .Conmed corp - surgiquest, is also liable for an additional $10.0 million in punitive damages.  Full Article

Conmed Q4 adjusted earnings per share $0.54
Wednesday, 1 Feb 2017 04:01pm EST 

Conmed Corp : Conmed Corporation announces fourth quarter and fiscal year 2016 financial results . Q4 adjusted earnings per share $0.54 . Q4 GAAP earnings per share $0.24 . Q4 earnings per share view $0.56 -- Thomson Reuters I/B/E/S . Q4 sales $204.1 million versus I/B/E/S view $204 million . Expects 2017 constant currency sales growth in range of 1% to 3% . Conmed Corp -Company forecasts adjusted diluted net earnings per share in range of $1.85 to $1.95 in 2017 .FY2017 earnings per share view $1.91, revenue view $784.7 million -- Thomson Reuters I/B/E/S.  Full Article

Bovie medical announces sales partnership with CONMED for PlazXact
Thursday, 19 Jan 2017 08:00am EST 

Bovie Medical Corp : Bovie Medical announce sales channel partnership with conmed for plazxact(tm) . Bovie Medical Corp - entered into global sales channel partnership agreement with conmed for its PlazXact ablator .Bovie Medical Corp - PlazXact ablator will be marketed as ultrablator bipolar series effective in March 2017.  Full Article

Conmed Corporation announces Q2 2016 financial results
Wednesday, 27 Jul 2016 04:01pm EDT 

Conmed Corp : Conmed corp sees 2016 adjusted diluted net earnings per share are now expected to be in range of $1.83 to $1.9 . Conmed corporation announces second quarter 2016 financial results . Q2 adjusted earnings per share $0.47 . Q2 gaap earnings per share $0.10 . Q2 sales $193.4 million versus i/b/e/s view $191.5 million . Q2 earnings per share view $0.46 -- Thomson Reuters I/B/E/S . Sees fy 2015 revenue $719 million .Than-Anticipated organic sales growth.  Full Article

Conmed Corporation announces quarterly cash dividend
Tuesday, 23 Feb 2016 08:00am EST 

Conmed Corporation:Board of Directors has declared a quarterly cash dividend of $0.20 per share.Payable on April 5 to all shareholders of record date as of March 15.  Full Article

Conmed Corporation gives FY 2016 guidance
Wednesday, 27 Jan 2016 04:01pm EST 

Conmed Corporation:Forecasts Fy 2016 sales to be in the range of $760 to $770 million.Fy 2016 Revenue forecast includes constant currency organic sales growth of 1% to 3%, sales related to the SurgiQuest acquisition of $55 to $60 million and the negative impact of foreign exchange of $21 to $23 million.Forecasts Fy 2016 adjusted diluted cash earnings per share to be in the range of $1.85 to $1.95.Adjusted diluted cash EPS estimates for Fy 2016 exclude cost of special items including acquisition costs and restructuring costs which are estimated to be in range of $18 to $20 million, net of tax, and amortization of intangible assets estimated to be in range of $14 to $16 million, net of tax.  Full Article

Conmed Corp Completes Acquisition of SurgiQuest, Inc
Monday, 4 Jan 2016 04:43pm EST 

CONMED Corporation:completed its previously announced acquisition of privately-held SurgiQuest, Inc. (SurgiQuest), which will become part of the CONMED Advanced Surgical business.  Full Article

BRIEF-Conmed Corporation Q2 earnings per share $0.22

* Conmed Corporation announces second quarter 2017 financial results